Phibro Animal Health reported $474.17M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Align Technology USD 120.84M 4.8M Jun/2026
ANI Pharmaceuticals USD 607.23M 3.26M Sep/2026
Aurora Cannabis CAD 22.68M 1.18M Jun/2026
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
Canopy Growth CAD 277.33M 1.38M Jun/2026
Corcept Therapeutics USD 8.99M 430K Sep/2026
Eli Lilly USD 54.91B 11.54B Jun/2026
Henry Schein USD 3.89B 78M Sep/2026
Idexx Laboratories USD 972.96M 123.12M Sep/2026
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Merck USD 53.91B 4.79B Jun/2026
Nektar Therapeutics USD 0 0 Jun/2022
Pacira USD 293.59M 69.53M Sep/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 2.07B 1.02B Jun/2026
Supernus Pharmaceuticals USD 40.17M 733K Jun/2026
Zoetis USD 9.24B 0 Jun/2026